Altered membrane-associated functions in chronic lymphocytic leukemia cells.
Peripheral blood lymphocytes consisting mainly of neoplastic B cells from patients with chronic lymphocytic leukemia (CLL cells) showed a markedly reduced response to the human B-cell mitogens anti-beta2 microglobulin, Sepharose-bound protein A and Sepharose-bound anti-human immunoglobulin (anti F(ab')2) in all of nine patients studied. On the other hand, CLL cells from three out of eight patients tested responded well to the calcium ionophore A23187. Sepharose-bound protein A and anti-beta2 microglobulin also failed to induce increased uptake of 86Rubidium (potassium analogue) in CLL cells as compared to B-cell-enriched preparations of normal peripheral blood lymphocytes. The capacity of CLL cells to cap various surface markers including beta2 microglobulin was reduced. On the other hand, surface concentrations of beta2 microglobulin were not reduced as measured by fluorescein-labelled anti-beta2-microglobulin in single-cell cytofluorometry. It is concluded that various membrane-associated events elicited by ligand-receptor interactions are altered or blocked in CLL cells.
D000368:Aged; D001402:B-Lymphocytes / Q000276:immunology; D000001:Calcimycin / Q000494:pharmacology; D002462:Cell Membrane / Q000276:immunology; D004247:DNA / Q000096:biosynthesis; D005260:Female; D006801:Humans; D007152:Immunologic Capping; D007945:Leukemia, Lymphoid / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology; D001613:beta 2-Microglobulin / Q000276:immunology
D008934:Mitogens; D001613:beta 2-Microglobulin; D000001:Calcimycin; D004247:DNA